Showing results (1-10 of 338) with videos related to

Sort By:
Pageof 34
Current Opinion in Gastroenterology|February 27, 2020
Liver transplantation for alcoholic hepatitis: updateBeshoy Yanny, Sandra Boutros, Fatima Saleh, et al.
Clinics in Liver Disease|September 30, 2019
Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic ApproachBeshoy Yanny, Adam Winters, Sandra Boutros, et al.
Journal of Clinical and Translational Hepatology|August 25, 2020
Approaches to Assessing Burden in Caregivers of Patients with CirrhosisBeshoy Yanny, Nguyen V Pham, Hussein Saleh, et al.
Gastroenterology & Hepatology|April 24, 2019
Management Approaches to Hepatitis B Virus Vaccination NonresponseBeshoy Yanny, Peter Konyn, Lisa M Najarian, et al.
Gastroenterology & Hepatology|October 11, 2018
Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C VirusSammy Saab, Timothy Ahn, Terina McDaniel, et al.
Journal of Clinical and Experimental Hepatology|November 7, 2022
Post-COVID-19 Cholangiopathy: A Systematic ReviewBeshoy Yanny, Mohammed Alkhero, Mohammed Alani, et al.
Translational Gastroenterology and Hepatology|May 8, 2024
Lower FIB-4 threshold in patients with diabetes improves diagnostic accuracy of the test in a Hispanic populationJasleen Singh, Brittney Ibrahim, Nicholas J Jackson, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|August 30, 2019
Everolimus worsening chronic proteinuria in patient with diabetic nephropathy post liver transplantationRamy M Hanna, Beshoy Yanny, Farid Arman, et al.
Journal of Viral Hepatitis|August 19, 2020
Estimating paediatric hepatitis C prevalence in the United StatesHarman Rahal, Sandra Boutros, Mohamad Farhat, et al.
Digestive Diseases and Sciences|September 28, 2018
Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mLBeshoy Yanny, Sammy Saab, Francisco Durazo, et al.
Pageof 34